Skip to content

Clinical trials

Phase 3 Renal Insufficiency, Chronic trials in Puerto Rico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 3 Country / region: Puerto Rico Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20077
20082
20091
20101
20123
20142
20154
20161
20173
20191
20202
20212
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated8
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Tanabe Pharma Corporation3
AbbVie2
Affymax2
Akebia Therapeutics2
Amgen2
AstraZeneca2
Kyntra Bio2
Pfizer2
AbbVie (prior sponsor, Abbott)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic34
Kidney Failure, Chronic11
Anemia10
Kidney Diseases8
Diabetes Mellitus, Type 27
Renal Insufficiency4
Cardiovascular Diseases2
Diabetic Nephropathies2
Hyperkalemia2
Hyperphosphatemia2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.